CROI 2014

CROI 2014 Header

The Conference on Retroviruses and Opportunistic Infections (CROI) is a scientifically focused meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. The goal of CROI is to provide a forum for translating laboratory and clinical research into progress against the AIDS epidemic. Over 4,000 leading researchers and clinicians from around the world will in Boston for the 21th Conference on Retroviruses and Opportunistic Infections.

Schedule of Events:
Full program is available on CROI website. Below is a list of talks and posters by researchers associated with the Harvard AIDS Initiative and the Botswana-Harvard AIDS Institute Partnership.

Monday, March 3, 2014

SESSION NL2 LECTURE
5:00 pm – 7:00 pm AUDITORIUM
N’Galy-Mann Lecture

Application of Scientific Knowledge and Evidence To Limit the Progression of HIV/AIDS and Fight Other Endemic Diseases in West Africa
Souleymane Mboup, Centre Hospitalier Universitaire Aristide le Dantec, Dakar, Senegal

Tuesday, March 4, 2014

SESSION TD4 THEMED DISCUSSION
1:30 pm – 2:30 pm ROOM 312
Response To Early ART Initiation in Infants

Early Viral Suppression Improves Neurocognitive Outcomes in HIV-Infected Children

Claudia S. Crowell, Yanling Huo, Katherine Tassiopoulos, Kathleen M. Malee, Ram Yogev, Rohan Hazra, Richard M. Rutstein, Sharon L. Nichols, Renee A. Smith, William J. Muller,
for the IMPAACT 219C Study Team and the PediatricHIV/AIDS Cohort Study

SESSION P-L2 POSTER SESSION
2:30 pm–4:00 pm EXHIBIT HALL B
Acquired HIV Drug Resistance

Acquired Drug-Resistance Mutations and Mortality Among HIV Patients On First-Line ART

Julia W. Wu, Hui Xing, Eric Tchetgen Tchetgen, Lingjie Liao, Shahin Lockman, Yuhua Ruan, Victor De Gruttola, Marc Lipsitch, George R. Seage, Yiming Shao

Wednesday, March 5, 2014

SESSION O-5 ABSTRACTS
10:00 am – 12:15 pm ROOM 304
Critical Issues in MTCT: Maternal Health and HIV Treatment in Children

Virologic Control by 1 Year of Age Significantly Reduces HIV-1 Reservoirs in Perinatal Infection

Deborah Persaud, Kunjal Patel, Brad Karalius, Carrie Ziemniak, Kaitlin Rainwater-Lovett, Ya Chen, Douglas D. Richman, George K. Siberry, Russell VanDyke, Katherine Luzuriaga, Pediatric HIV/AIDS Cohort Study (PHACS) and IMPAACT Network

SESSION P-R2 POSTER SESSION
2:30 pm–4:00 pm EXHIBIT HALL D
TB Screening and Diagnosis

Screening for Tuberculosis in HIV-Infected Nigerian Children With a Urinary Antigen Assay

Holly E. Rawizza, Stephen Oguche, Godwin Imade, Oche Agbaji, David Olaleye, Georgina Odaibo, Kike Osinusi, Isaac Adewole, Prosper Okonkwo, Phyllis Kanki

Thursday, March 6, 2014

SESSION S8 SYMPOSIUM
4:00 pm – 6:00 pm ROOM 311
The Road To Elimination: Preventing and Treating HIV Infection in Infants

No Free Rides: Consequences of Fetal & Infant ARV Exposure Among Children Remaining HIV
Uninfected

Kathleen M. Powis
Harvard Medical School, Boston, MA, United States

SESSION P-E7 POSTER SESSION
2:30 pm–4:00 pm EXHIBIT HALL B
Immune Response To Infection

Characterizing Acute HIV-1B CTL Escape by Full- Genome “Deep” Sequencing

Christian L. Boutwell, Damien Tully, Rebecca Batorsky, Karen Power, Aaron Seese, Michael Sirignano, Marcus Altfeld, Todd M. Allen

SESSION P-J2 POSTER SESSION
2:30 pm–4:00 pm EXHIBIT HALL B
RCTs in First-Line ART in Treatment Naive Patients

NEGR1 Genetic Variants and Risk for Virological Failure With Genotypic Resistance in Botswana

Sophie Limou, Cheryl A. Winkler, Hermann Bussmann, Vladimir Novitsky, Sikhulile Moyo, Max Essex, Richard G. Marlink, C. William Wester

SESSION P-K3 POSTER SESSION
2:30 pm–4:00 pm EXHIBIT HALL B
ART: Adherence and Retention

Immune, Virologic and Adherence Measures as Time-Dependent Predictors of Loss To Follow-Up

Seema T. Meloni, Charlotte Chang, Doug Hoi Cheung, Beth Chaplin, Holly Rawizza, Oluwatoyin Jolayemi, Bolanle Banigbe, Prosper Okonkwo, Phyllis Kanki

SESSION P-L5 POSTER SESSION
2:30 pm–4:00 pm EXHIBIT HALL B
Laboratory Detection of Drug Resistance and Tropism

Pan Degenerate Amplification and Adaptation for Highly Sensitive Detection of ARV Drug Resistance

Iain J. MacLeod, Christopher F. Rowley, M. Essex

SESSION P-Q9 POSTER SESSION
2:30 pm–4:00 pm EXHIBIT HALL D
Genetic Factors and ART Outcomes

Large-Scale Gene-Centric Exploration of Risk for NRTI/NNRTI-Associated Toxicities in Botswana

C. William Wester, Sophie Limou, Hermann Bussmann, Vladimir Novitsky, Sikhulile Moyo, Max Essex, Richard G. Marlink, Cheryl A. Winkler

SESSION P-T8 POSTER SESSION
2:30 pm–4:00 pm EXHIBIT HALL D
PMTCT Approaches: Implementation and Outcome

Programmatic Implementation of WHO Option B in Botswana Associated With Increased Projected MTCT

Scott Dryden-Peterson, Sajini Souda, Rebecca Zash, Jennifer Chen, Chipo Petlo, Eldah N. Dintwa, Refeltetswe Lebelonyane, Mompati Mmalane, Shahin Lockman, Roger L. Shapiro

SESSION P-X1 POSTER SESSION
2:30 pm–4:00 pm EXHIBIT HALL D
HIV Testing in Low Income Settings

HTC Campaign in Households Reached the Majority of Women But Only 50% of Men in Botswana Community

Vlad Novitsky1, Hermann Bussmann, Sikhulile Moyo, Erik van Widenfelt, Mompati Mmalane, Quanhong Lei, Joseph Makhema, Shahin Lockman, Victor DeGruttola, Max Essex

About Martha S Henry

Martha Henry is the Director of Communications for the Harvard T.H. Chan School of Public Health AIDS Initiative.